Friday, April 08, 2005

Canada joins U.S., European regulators asking Pfizer to halt Bextra sales

From CBC News:
The class of drugs known as cox-2 inhibitors took another major hit Thursday as regulatory agencies in the United States and the European Union asked pharmaceutical giant Pfizer to withdraw Bextra, its eighth-best seller globally, from the market.

Health Canada followed with a temporary suspension while it completes a review of the drug that could lead to the same conclusion.

"In Canada, since there is that voluntary withdrawal in the States, we feel that while we complete our own evaluation about this specific topic, it's the best thing to withdraw the product temporarily. And the manufacturer has agreed to that," Dr. Marc Berthiaume, Health Canada's manager of marketed pharmaceuticals, said during a media teleconference. ...more

No comments: